United Therapeutics (UTHR): Chairperson & CEO Rothblatt Martine A sold $5,650,415 worth of shares (9,500 units at $594.78) as part of a pre-agreed trading plan (SEC Form 4)
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for UTHR
Across the 28 sessions after earlier UTHR headlines, the stock closed higher 16 times and lower 12 times, with a median move of 1.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | UTHR | SPY |
|---|---|---|---|
| Oct 28, 2026 | United Therapeutics Announces FDA Clearance to Proceed with Clinical Trial for Treprostinil-Iloprost SMI in Pulmonary Arterial Hypertension | -0.8% | +0.3% |
| Oct 22, 2026 | United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization | +3.8% | -1.2% |
| Oct 21, 2026 | United Therapeutics Corporation to Report Third Quarter 2026 Financial Results Before Market Open on Wednesday, November 4, 2026 | +1.7% | +0.5% |
| Oct 20, 2026 | United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility | +2.0% | +0.3% |
| Oct 19, 2026 | United Therapeutics Announces FDA Clearance to Proceed with SUMMIT Clinical Trial for Treprostinil SMI in PH-COPD | +1.9% | +0.4% |
| Oct 13, 2026 | United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting | -1.2% | -0.0% |
Earlier insider filings at UTHR
- Oct 29, 2026Chairperson & CEO Rothblatt Martine A sold $5,562,190 worth of shares (9,500 units at $585.49) as part of a pre-agreed trading plan (SEC Form 4)
- Oct 28, 2026Chairperson & CEO Rothblatt Martine A sold $5,583,418 worth of shares (9,500 units at $587.73) as part of a pre-agreed trading plan (SEC Form 4)
- Oct 27, 2026Chairperson & CEO Rothblatt Martine A sold $5,592,095 worth of shares (9,500 units at $588.64) as part of a pre-agreed trading plan (SEC Form 4)
- Oct 26, 2026Chairperson & CEO Rothblatt Martine A sold $5,536,235 worth of shares (9,500 units at $582.76) as part of a pre-agreed trading plan (SEC Form 4)
- Oct 23, 2026Chairperson & CEO Rothblatt Martine A sold $5,542,094 worth of shares (9,500 units at $583.38) as part of a pre-agreed trading plan (SEC Form 4)
Quantisnow market dataNASDAQ
UTHR
United Therapeutics Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 1999
Get push alerts for UTHR
Full UTHR profile on Quantisnow Follow UTHR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time